F13.929
Sedative, hypnotic or anxiolytic use, unspecified with intoxication, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.929 refers to cases where an individual has experienced intoxication due to the use of unspecified sedatives, hypnotics, or anxiolytics. These medications are often prescribed to help manage anxiety, promote sleep, or relax the body, but misuse or accidental overdose can lead to intoxication. This code indicates that the specific medication and severity of intoxication are not detailed, highlighting the need for comprehensive assessment and care.
Causes & Symptoms
Clinical Causes: Misuse or abuse of prescribed sedatives, hypnotics, or anxiolytics Accidental overdose, especially when multiple medications are used concurrently Taking medications in higher doses than prescribed Combining prescribed medications with alcohol or other central nervous system depressants Lack of proper supervision during medication use Inadequate understanding of medication effects and risks
Key Symptoms: Confusion or disorientation Drowsiness or excessive sleepiness Impaired coordination or motor skills Slurred speech Respiratory depression or slowed breathing Dizziness or lightheadedness Itching or skin reactions Nausea or vomiting Loss of consciousness in severe cases Behavioral changes such as agitation or decreased responsiveness
Diagnostic & Treatment
Diagnosis Path: Diagnosis of intoxication with sedatives, hypnotics, or anxiolytics involves a comprehensive clinical evaluation. Healthcare providers typically review the patient's medical history, medication use, and recent behavior. Physical examinations assess neurological and respiratory status. Laboratory tests, such as blood or urine analyses, may be performed to detect the presence and levels of the substances involved. The absence of in-depth details about the specific medication and quantity emphasizes the importance of thorough assessment to determine the severity of intoxication and guide appropriate care.
Treatment Protocols: Management of intoxication from sedatives, hypnotics, or anxiolytics focuses on supporting vital functions and preventing complications. Initial steps might include monitoring vital signs, ensuring airway patency, and providing respiratory support if needed. Activated charcoal may be administered in certain cases to limit absorption from the gastrointestinal tract. In severe situations, specific antidotes such as flumazenil might be used, although their application depends on the substance involved and the patient's condition. Continuous monitoring is vital, and in critical cases, hospitalization may be necessary to provide intensive care. Once stabilized, addressing the underlying cause of misuse, offering psychological support, and planning appropriate follow-up care are crucial to prevent future incidents.
Clinical Advice & FAQs
Billing Guidance
Is F13.929 a billable ICD-10 code?
Yes, F13.929 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.929?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic use, unspecified with intoxication, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
